Considerations for the Use of Human-and Animal-Derived Materials in the Manufacture of Cell and Gene Therapy and Tissue-Engineered Medical Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 29, 2024
May 15, 2024
3d5c2c78-6224-49f7-8c61-e72d9219b413
Related Documents
Potency Assurance for Cellular and Gene Therapy Products
Guidance DocumentDecember 27, 2023Center for Biologics Evaluation and Research
Frequently Asked Questions — Developing Potential Cellular and Gene Therapy Products
Guidance DocumentNovember 18, 2024Center for Biologics Evaluation and Research
Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products
Guidance DocumentJuly 13, 2023Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox